Search research articles
Contact Us
Filters
Showing results (101-110 of 158) with videos related to
Page
of 16
Sort By:
Journal of Environmental Management
|
January 13, 2022
Integrating life cycle assessment and characterisation techniques: A case study of biodiesel production utilising waste Prunus Armeniaca seeds (PAS) and a novel catalyst
Ala'a H Al-Muhtaseb, Ahmed I Osman, Farrukh Jamil, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
LAIR1 prevents excess inflammatory tissue damage in <i>S. aureus</i> skin infection and Cutaneous T-cell Lymphoma
Hannah K Dorando, Evan C Mutic, Kelly L Tomaszewski, et al.
Clinical Pharmacology and Therapeutics
|
December 16, 2023
Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision Medicine
Kunal Naik, Rahul K Goyal, Luca Foschini, et al.
Environmental Microbiology
|
December 22, 2022
Widespread formation of intracellular calcium carbonates by the bloom-forming cyanobacterium Microcystis
Juliette Gaëtan, Sébastien Halary, Maxime Millet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2019
Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study
Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, et al.
Blood Advances
|
June 23, 2023
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up
Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, et al.
JCI Insight
|
November 13, 2025
LAIR1 prevents excess inflammatory tissue damage in Staphylococcus aureus skin infection and Cutaneous T-cell Lymphoma
Hannah K Dorando, Evan C Mutic, Kelly L Tomaszewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2026
Duvelisib Induces Deep Responses in PTCL: Final Results of the Phase 2 PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma
Neha Mehta-Shah, Pier Luigi Zinzani, Eric D Jacobsen, et al.
Blood Advances
|
October 23, 2023
Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
Armin Ghobadi, Nicole C Foley, Jared Cohen, et al.
British Journal of Haematology
|
May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma
Robert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 158) with videos related to
Sort By:
Page
of 16
Journal of Environmental Management
|
January 13, 2022
Integrating life cycle assessment and characterisation techniques: A case study of biodiesel production utilising waste Prunus Armeniaca seeds (PAS) and a novel catalyst
Ala'a H Al-Muhtaseb, Ahmed I Osman, Farrukh Jamil, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
LAIR1 prevents excess inflammatory tissue damage in <i>S. aureus</i> skin infection and Cutaneous T-cell Lymphoma
Hannah K Dorando, Evan C Mutic, Kelly L Tomaszewski, et al.
Clinical Pharmacology and Therapeutics
|
December 16, 2023
Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision Medicine
Kunal Naik, Rahul K Goyal, Luca Foschini, et al.
Environmental Microbiology
|
December 22, 2022
Widespread formation of intracellular calcium carbonates by the bloom-forming cyanobacterium Microcystis
Juliette Gaëtan, Sébastien Halary, Maxime Millet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2019
Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study
Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, et al.
Blood Advances
|
June 23, 2023
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up
Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, et al.
JCI Insight
|
November 13, 2025
LAIR1 prevents excess inflammatory tissue damage in Staphylococcus aureus skin infection and Cutaneous T-cell Lymphoma
Hannah K Dorando, Evan C Mutic, Kelly L Tomaszewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2026
Duvelisib Induces Deep Responses in PTCL: Final Results of the Phase 2 PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma
Neha Mehta-Shah, Pier Luigi Zinzani, Eric D Jacobsen, et al.
Blood Advances
|
October 23, 2023
Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
Armin Ghobadi, Nicole C Foley, Jared Cohen, et al.
British Journal of Haematology
|
May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma
Robert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Page
of 16